OBJECTIVES: To generate non-haematopoietic tissues from mobilized haematopoietic CD133(+) stem cells. MATERIALS AND METHODS: Mobilized peripheral blood CD133(+) cells from adult healthy donors were used. In vitro ability of highly enriched CD133(+) cells from mobilized peripheral blood to generate multipotent cells, and their potential to give rise to cells with characteristics of neuroectoderm, endoderm and mesoderm layers was investigated. RESULTS: We found that a recently identified population of CD45(+) adherent cells generated in vitro after culture of highly purified CD133(+) cells for 3-5 weeks with Flt3/Flk2 ligand and interleukin-6 can, in presence of the appropriate microenvironmental cues, differentiate into neural progenitor-like cells (NPLCs), hepatocyte-like cells and skeletal muscle-like cells. We have termed them to be adult multipotent haematopoietic cells (AMHCs). AMHC-derived NPLCs expressed morphological, phenotypic and molecular markers associated with primary neural progenitor cells. They can differentiate into astrocyte-like cells, neuronal-like cells and oligodendrocyte-like cells. Moreover, AMHC-derived NPLCs produced 3,4-dihydrophenylalanine and dopamine and expressed voltage-activated ion channels, suggesting their functional maturation. In addition, AMHC-derived hepatocyte-like cells and skeletal muscle-like cells, showed typical morphological features and expressed primary tissue-associated proteins. CONCLUSION: Our data demonstrate that AMHCs may therefore serve as a novel source of adult multipotent cells for autologous replacement cell therapies.
OBJECTIVES: To generate non-haematopoietic tissues from mobilized haematopoietic CD133(+) stem cells. MATERIALS AND METHODS: Mobilized peripheral blood CD133(+) cells from adult healthy donors were used. In vitro ability of highly enriched CD133(+) cells from mobilized peripheral blood to generate multipotent cells, and their potential to give rise to cells with characteristics of neuroectoderm, endoderm and mesoderm layers was investigated. RESULTS: We found that a recently identified population of CD45(+) adherent cells generated in vitro after culture of highly purified CD133(+) cells for 3-5 weeks with Flt3/Flk2 ligand and interleukin-6 can, in presence of the appropriate microenvironmental cues, differentiate into neural progenitor-like cells (NPLCs), hepatocyte-like cells and skeletal muscle-like cells. We have termed them to be adult multipotent haematopoietic cells (AMHCs). AMHC-derived NPLCs expressed morphological, phenotypic and molecular markers associated with primary neural progenitor cells. They can differentiate into astrocyte-like cells, neuronal-like cells and oligodendrocyte-like cells. Moreover, AMHC-derived NPLCs produced 3,4-dihydrophenylalanine and dopamine and expressed voltage-activated ion channels, suggesting their functional maturation. In addition, AMHC-derived hepatocyte-like cells and skeletal muscle-like cells, showed typical morphological features and expressed primary tissue-associated proteins. CONCLUSION: Our data demonstrate that AMHCs may therefore serve as a novel source of adult multipotent cells for autologous replacement cell therapies.
Authors: Yoon-Young Jang; Michael I Collector; Stephen B Baylin; Anna Mae Diehl; Saul J Sharkis Journal: Nat Cell Biol Date: 2004-05-09 Impact factor: 28.824
Authors: Raewyn M Seaberg; Simon R Smukler; Timothy J Kieffer; Grigori Enikolopov; Zeenat Asghar; Michael B Wheeler; Gregory Korbutt; Derek van der Kooy Journal: Nat Biotechnol Date: 2004-08-22 Impact factor: 54.908
Authors: Rupert Handgretinger; Paul R Gordon; Thasia Leimig; Xiaohua Chen; Hans-Jorg Buhring; Dietrich Niethammer; Selim Kuci Journal: Ann N Y Acad Sci Date: 2003-05 Impact factor: 5.691
Authors: Maria Teresa González-Garza; Delia E Cruz-Vega; Alejandro Cárdenas-Lopez; Rosa Maria de la Rosa; Jorge E Moreno-Cuevas Journal: Am J Stem Cells Date: 2018-06-01
Authors: Antonin Bukovsky; Michael R Caudle; Ray J Carson; Francisco Gaytán; Mahmoud Huleihel; Andrea Kruse; Heide Schatten; Carlos M Telleria Journal: Aging (Albany NY) Date: 2009-02-13 Impact factor: 5.682
Authors: Maria Teresa González-Garza; Héctor R Martínez; Enrique Caro-Osorio; Delia E Cruz-Vega; Martin Hernández-Torre; Jorge E Moreno-Cuevas Journal: Stem Cells Transl Med Date: 2013-01-22 Impact factor: 6.940
Authors: Branislava Janic; Kourosh Jafari-Khouzani; Abbas Babajani-Feremi; A S M Iskander; Nadimpalli Ravi S Varma; Meser M Ali; Robert A Knight; Ali S Arbab Journal: PLoS One Date: 2012-05-25 Impact factor: 3.240
Authors: Joan E Nichols; Jean A Niles; Douglas DeWitt; Donald Prough; Margaret Parsley; Stephanie Vega; Andrea Cantu; Eric Lee; Joaquin Cortiella Journal: Stem Cell Res Ther Date: 2013-01-06 Impact factor: 6.832
Authors: Branislava Janic; Austin M Guo; A S M Iskander; Nadimpalli Ravi S Varma; Alfonso G Scicli; Ali S Arbab Journal: PLoS One Date: 2010-02-11 Impact factor: 3.240